Please use this identifier to cite or link to this item:
|Title:||Bartter's and Gitelman's syndromes: from gene to clinic||Authors:||Naesens, Maarten
|Issue Date:||2004||Source:||NEPHRON PHYSIOLOGY, 96(3). p. 65-78||Abstract:||Bartter's and Gitelman's syndromes are characterized by hypokalemia, normal to low blood pressure and hypochloremic metabolic alkalosis. Recently, investigators have been able to demonstrate mutations of six genes encoding several renal tubular transporters and ion channels that can be held responsible for Bartter's and Gitelman's syndromes. Neonatal Bartter's syndrome is caused by mutations of NKCC2 or ROMK, classic Bartter's syndrome by mutations of ClC-Kb, Bartter's syndrome associated with sensorineural deafness is due to mutations of BSND, Gitelman's syndrome to mutations of NCCT and Bartter's syndrome associated with autosomal dominant hypocalcemia is linked to mutations of CASR. We review the pathophysiology of these syndromes in relation to their clinical presentation.||Document URI:||http://hdl.handle.net/1942/4884||ISSN:||1660-2137||DOI:||10.1159/000076752||Rights:||Copyright 2004 S. Karger AG, Basel.||Category:||A2||Type:||Journal Contribution|
|Appears in Collections:||Research publications|
Show full item record
checked on Sep 3, 2020
checked on May 25, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.